en sv

NextCell´s CEO invited speaker at National conference on Clinical Studies


Cellaviva Sverige - February 7, 2019 - 0 comments

NextCell Pharma AB (“NXTCL”) announces that its CEO, Mathias Svahn PhD has been invited to speak at the 2019 National Conference on Clinical Studies.

The conference, which is held in Malmö and arranged by the national initiative Clinical Studies Sweden, a collaboration between Vetenskapsrådet (Swedish Research Council) and Sweden´s six healthcare regions, brings together researchers, politicians, and others who are active in the Life Science area. The scope of the event is knowledge exchange and networking, with the topic for the year being “The Value of Clinical studies”. Examples of issues raised are the value clinical studies create and how Sweden should focus their work within Life Science. Mathias Svahn’s presentation will elaborate on the work and progress in the ongoing clinical study with drug candidate ProTrans, which NXTCL is currently conducting and the value that the study is expected to generate.

Stay up to date with the latest development in NextCell Pharma

LinkedIn: https://www.linkedin.com/company/15255207/

Twitter: https://twitter.com/NextCellPharma

For more information about NextCell Pharma AB, please contact:

Mathias Svahn, CEO

Sofia Fredrikson, CFO

Phone: 08-735 5595

E-mail: info@nextcellpharma.com

www.nextcellpharma.com